Open an account

AquaBounty Technologies

AQB · NASDAQ

$1.15+$0.11 (+10.58%)TodayMarket closed ·
Prev close $1.04

About AQB

AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 3 full-time employees. The company went IPO on 2017-01-09. The Company’s technology advances in fish breeding, genetics, and health and nutrition. The company locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.

Employees
3
Headquarters
Harvard, Massachusetts
Listed
Jan 9, 2017
Sector
Health Care
Industry
Biotechnology
Website
investors.aquabounty.com

AQB key statistics

Market cap
6.00M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
106.46K
Volume
64.86K
Open price
$1.05
High today
$1.16
Low today
$1.04
52 Week high
$1.73
52 Week low
$0.7742

AquaBounty Technologies (AQB) at a glance

As of Oct 20, 2026, AquaBounty Technologies (AQB) shares are priced at $1.15, giving the company a market cap of 6.00M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.04 and $1.16. The current price is 10.5% above the day's low and 0.9% below its high.

Volume so far is 64.86K shares, below the average of 106.46K shares a day.

Over the past year AquaBounty Technologies has ranged from $0.7742 to $1.73, and now sits 39% of the way up that range.

AquaBounty Technologies met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q3 FY24 it reported -$0.88 per share against an estimate of -$0.8939.

AQB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 8.3% on average.

  1. Q4 FY22: reported -$1.60 per share against an estimate of -$1.68
  2. Q1 FY23: reported -$1.80 per share against an estimate of -$1.62
  3. Q2 FY23: reported -$1.80 per share against an estimate of -$1.68
  4. Q3 FY23: reported -$1.60 per share against an estimate of -$1.96
  5. Q4 FY23: reported -$2.19 per share against an estimate of -$1.55
  6. Q1 FY24: reported -$2.90 per share against an estimate of -$1.54
  7. Q2 FY24: reported -$1.57 per share against an estimate of -$1.16
  8. Q3 FY24: reported -$0.88 per share against an estimate of -$0.8939

AQB news

  • Caroline Ryan

    Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy

  • Mohd Haider

    AquaBounty Technologies Stock Surges Over 54% Overnight: Why is it Moving?

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Mohd Haider

    AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Avi Kapoor

    US Stocks Mixed; Nvidia Posts Upbeat Earnings

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

Similar companies

Companies in the same industry as AquaBounty Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.